Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Glaukos Corp
(NY:
GKOS
)
131.77
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Glaukos Corp
< Previous
1
2
3
4
5
6
7
8
Next >
Glaukos Announces Submission of Supplemental Pre-Market Approval Application for iStent infinite™
September 03, 2021
From
Glaukos Corporation
Via
Business Wire
Return on Capital Employed Overview: Glaukos
September 01, 2021
Pulled from Benzinga Pro data Glaukos (NYSE:GKOS) reported Q2 sales of $78.09 million. Earnings fell to a loss of $14.22 million, resulting in a 20.47% decrease from last quarter...
Via
Benzinga
Glaukos Announces Participation in the Wells Fargo Healthcare Conference
August 26, 2021
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Market-Leading Clinical Milestone of 200 Peer-Reviewed Publications on iStent® Technologies
August 23, 2021
From
Glaukos Corporation
Via
Business Wire
Why Glaukos Shares Dipped Today
July 20, 2021
Glaukos (NYSE:GKOS) shares are trading lower after Wells Far...
Via
Benzinga
Glaukos plunges after CMS suggests slashing iStent reimbursement
July 14, 2021
William Blair downgraded Glaukos following the
Via
Talk Markets
Glaukos Guided Below Consensus After Q2 Earnings; Analysts Cut Price Target
August 06, 2021
Glaukos Corporation (NYSE:GKOS)
Via
Benzinga
Glaukos Corp (GKOS) Q2 2021 Earnings Call Transcript
August 06, 2021
GKOS earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Glaukos Corporation Announces Second Quarter 2021 Financial Results
August 05, 2021
From
Glaukos Corporation
Via
Business Wire
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Society of Cataract and Refractive Surgery Annual Meeting
July 22, 2021
From
Glaukos Corporation
Via
Business Wire
Why Glaukos Stock Sank Today
July 20, 2021
An analyst downgraded the healthcare stock.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2021
July 26, 2021
Upgrades Tudor Pickering upgraded the previous rating for Precision Drilling Corp (NYSE:
Via
Benzinga
62 Biggest Movers From Yesterday
July 21, 2021
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment...
Via
Benzinga
Exposures
Product Safety
Wells Fargo Downgrades Glaukos To Sell On iStent Reimbursement Cuts
July 20, 2021
Wells Fargo analyst Lawrence Biegelsen downgraded Glaukos to Underweight from Equal Weight with a price target of $41, down from $100.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021
July 20, 2021
Upgrades For Bank of Marin Bancorp (NASDAQ:
Via
Benzinga
Glaukos Corporation to Release Second Quarter 2021 Financial Results after Market Close on August 5
July 15, 2021
From
Glaukos Corporation
Via
Business Wire
Mid-Afternoon Market Update: Dow Gains 50 Points; Imara Shares Plunge
July 14, 2021
Toward the end of trading Wednesday, the Dow traded up 0.15% to 34,942.77 while the NASDAQ rose 0.07% to 14,687.21. The S&P also rose, gaining 0.26% to 4,380.58. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
55 Biggest Movers From Yesterday
July 15, 2021
Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares gained 37.6% to settle at $13.20 on Wednesday. SGOCO Group regained compliance with Nasdaq's listing standards on July 12 by...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 14, 2021
Gainers AcelRx Pharmaceuticals (NASDAQ:ACRX
Via
Benzinga
Mid-Day Market Update: Aspen Group Drops Following Q4 Results; Datasea Shares Surge
July 14, 2021
Midway through trading Wednesday, the Dow traded up 0.05% to 34,907.35 while the NASDAQ rose 0.48% to 14,747.61. The S&P also rose, gaining 0.24% to 4,379.85. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
34 Stocks Moving In Wednesday's Mid-Day Session
July 14, 2021
Gainers Datasea Inc. (NASDAQ: DTSS) climbed 85% to $5.42. Datasea’s subsidiary Shuhai Zhangxun Information Technology Co., Ltd inked six purchase and distribution...
Via
Benzinga
Why Glaukos Stock Is Tanking Today
July 14, 2021
Proposed rates from CMS for fiscal 2022 weren't what investors expected.
Via
The Motley Fool
Mid-Morning Market Update: Markets Open Higher; Citigroup Earnings Beat Expectations
July 14, 2021
Following the market opening Wednesday, the Dow traded up 0.26% to 34,979.05 while the NASDAQ rose 0.40% to 14,736.66. The S&P also rose, gaining 0.30% to 4,382.38. The U.S....
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021
July 14, 2021
Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 14, 2021
Gainers Qualigen Therapeutics (NASDAQ:QLGN) stock moved upwards by 8.98% to $1.94 during Wednesday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
William Blair Downgrades Glaukos After Disappointing CMS Rate; Shares Drop
July 14, 2021
Centers for Medicare and Medicaid Services (CMS) issued its fiscal 2022 proposed physician fee schedule, which included two combined Category I cataract plus stent procedure...
Via
Benzinga
Glaukos Comments on the Centers for Medicare and Medicaid Services 2022 Proposed Physician Fee Schedule
July 14, 2021
From
Glaukos Corporation
Via
Business Wire
Glaukos Stock Sees Its Relative Strength Rating Improve To Key Above-80 Level
July 01, 2021
Glaukos stock had its Relative Strength (RS) Rating upgraded from 78 to 81 Thursday. Is Glaukos on your watchlist?
Via
Investor's Business Daily
Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in U.S. NDA Phase 3 Clinical Trials for iDose® TR
June 10, 2021
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Australia’s TGA Regulatory Approval for PRESERFLO™ MicroShunt
June 08, 2021
From
Glaukos
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.